Clinical studies recruiting near Belo Horizonte

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-21020, Belo Horizonte, Minas Gerais · Colorado Prevention Center · NCT06024746 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Santa Casa de Misericordia de Belo Horizonte · Amgen · NCT07037433 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Bayer · NCT07192952 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Santa Casa de Belo Horizonte · Boehringer Ingelheim · NCT06531824 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Santa Casa de Misericórdia de Belo Horizonte · Biogen · NCT06962800 Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Phase 4 · Hospital Vera Cruz, Belo Horizonte, MG, Brazil · Science Valley Research Institute · NCT06958588 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Freire Pesquisa Clínica - Belo Horizonte - Rua Piauí- Site N · Sanofi · NCT06290128 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · Belo Horizonte, Minas Gerais · Colorado Prevention Center · NCT06033950 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Cetus Oncologia - Unidade Belo Horizonte · Bristol-Myers Squibb · NCT06561386 A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Bo
Phase 3 · Bayer · NCT07188805 WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · WISPer Site in Belo Horizonte, Brazil · Mediar Therapeutics · NCT06967805 A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, a
Phase 3 · Bayer · NCT05196035 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Santa Casa de Misericordia de Belo Horizonte · Janssen Research & Development, LLC · NCT05552222 Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Phase 3 · Santa Casa de Misericordia de Belo Horizonte · Nuvalent Inc. · NCT06765109 MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · Centro de Pesquisa NUPEC - Instituto Orizonti em Belo Horizo · Intellia Therapeutics · NCT06128629 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participa
Phase 3 · Amgen · NCT06252649 Peripheral Autonomic Block (BAP) Plus Transversus Abdominis Plane Block (TAP) for Postoperative Analgesia After Minimall
NA · Santa Casa de Misericórdia de Belo Horizonte · Faculdade de Ciências Médicas de Minas Gerais · NCT07388953 A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With
Phase 3 · Santa Casa de Misericordia de Belo Horizonte · Bristol-Myers Squibb · NCT06869551 A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor
Phase 3 · Bayer · NCT05457283 A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · Freire Pesquisa Clínica - Belo Horizonte - Rua Piauí- Site N · Sanofi · NCT06290141 A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants Wit
Phase 3 · Cetus Oncologia - Unidade Belo Horizonte · Celgene · NCT06764485 A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participan
Phase 3 · Cetus Oncologia - Unidade Belo Horizonte · Mirati Therapeutics Inc. · NCT06875310 A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA
Phase 3 · Santa Casa de Misericordia de Belo Horizonte - PPDS · Hoffmann-La Roche · NCT05797610 A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure P
Phase 3 · Belo Horizonte, Minais Gerais Investigative Site 21013 · Colorado Prevention Center · NCT06008197 Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Phase 3 · INRET Clínica/ Santa Casa de Misericórdia de Belo Horizonte · Laboratoires Thea · NCT06891443 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · Centro de Pesquisa do Hospital Evangelico de Belo Horizonte · Boehringer Ingelheim · NCT07064473 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · Santa Casa de Misericórdia de Belo Horizonte · Vertex Pharmaceuticals Incorporated · NCT05312879 A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, o
Phase 2/Phase 3 · Oncocentro - Belo Horizonte · Daiichi Sankyo · NCT06161025 Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (
Phase 2/Phase 3 · Santa Casa de Misericordia de Belo Horizonte · CSL Behring · NCT05485961 A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and
Phase 3 · NUPEC - Cardio · Eli Lilly and Company · NCT07241390

Look up another city

Look up another condition